
Palborest 75mg Tablet
Marketer
MSN Laboratories
Salt Composition
Palbociclib (75mg)
Overview Palborest 75mg Tablet
Estrogen receptor-positive, HER2-negative metastatic breast cancer is treated with the 75mg Palborest tablet, administered alongside hormonal cancer therapies. Consistent daily intake, ideally with food, maximizes effectiveness; dosage and frequency are determined by your physician based on your condition and may vary. Adhere strictly to your doctor's instructions, as incorrect usage or overdose can lead to severe adverse effects. Therapeutic benefits may take weeks or months to manifest; discontinue only upon your doctor's advice. Common side effects encompass fatigue, alopecia, skin rashes, emesis, and diarrhea. Reduced blood cell counts (leukopenia and anemia), increasing infection risk, are possible; report fever, chills, weakness, bleeding, bruising, or epistaxis immediately. Dizziness may occur; avoid driving or activities requiring focus if affected. Prior to commencing treatment, disclose any pre-existing heart, liver, or kidney conditions, and all other medications, particularly those combating infection, as drug interactions are possible. Pregnancy and breastfeeding are contraindicated. Reliable contraception for both partners is crucial throughout treatment to prevent conception.
Primary Ingredients of Palborest 75mg Tablet
No text provided. Please provide the text you wish to be rewritten.
Uses of Palborest 75mg Tablet
Malignant breast tumor
Major Benefits of Palborest 75mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the 75mg Palborest tablet whole; avoid chewing, crushing, or fracturing it. Take it with a meal.
Common Side effects of Palborest 75mg Tablet:
- Decreased blood cells (red cells, white cells, and platelets)
- Fatigue
- Hair loss
- Rash
- Vomiting
- Diarrhea
- Nausea
- Decreased appetite
- Infection
- Decreased white blood cell count
- Stomatitis (Inflammation of the mouth)
- Anemia (low number of red blood cells)
- Weakness
- Fever
How to use Palborest 75mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Palborest 75mg Tablets. Ingest each tablet whole; do not crush, chew, or break it. Consume with food.
How Palborest 75mg Tablet works:
Palborest 75mg tablets combat cancer by targeting key cell growth regulators. Specifically, it blocks cyclin-dependent kinases 4 and 6, enzymes crucial to cellular proliferation. This action halts the cancerous cell cycle. Furthermore, the medication effectively counters the growth of estrogen receptor-positive breast cancers by interfering with their cellular replication mechanisms.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction between Palborest 75mg Tablet and alcohol is undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Taking Palborest 75mg tablets during pregnancy poses a known risk to the fetus. Prescribing it is therefore generally avoided. Nevertheless, a physician might exceptionally recommend its use in critical circumstances where the potential advantages outweigh the hazards. Always seek medical advice.
Breast feedingUNSAFE
Lactation and the use of Palborest 75mg tablets are incompatible. Evidence indicates potential infant harm from this medication.
DrivingUNSAFE
Driving ability may be impaired by Palborest 75mg Tablets, as they can induce fatigue in certain individuals. If this occurs, operating machinery or vehicles requires extra care.
KidneySAFE IF PRESCRIBED
Palborest 75mg tablets pose no safety concerns for patients with renal impairment; dosage modification is unnecessary.
LiverCAUTION
Patients with liver impairment should use Palborest 75mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Palborest 75mg Tablet :
NA
Facts to Know About Palborest 75mg Tablet
Label | Value |
---|---|
Chemical Type | Piperazine-pyridines |
Developing Habits | No. |
Treatment Category | Cancer Medications |
Active Class | CDK Inhibitor |